Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carlos E. Peredo"'
Autor:
Alan D. Bennett, Barbara Tavano, Sara Brett, Manoj Saini, Adriano Quattrini, David J. Figueroa, Katherine L Crossland, Terri V Cornforth, Cedrik M. Britten, Joanna E. Brewer, Caitriona O'Connor, Jonathan D. Silk, Dylan Steiner, Alistair G Rust, Andrew B. Gerry, Ryan Wong, Katherine Adams, Joseph P. Sanderson, Annette Pachnio, Carlos E Peredo, Preetha Viswanathan, Junping Jing, Rachel J. M. Abbott, Guy E. Wiedermann, Laura L. Quinn, Lea Patasic, Bent K. Jakobsen
Publikováno v:
The Journal of Immunology. 208:169-180
Adoptive T cell therapy with T cells expressing affinity-enhanced TCRs has shown promising results in phase 1/2 clinical trials for solid and hematological tumors. However, depth and durability of responses to adoptive T cell therapy can suffer from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c2e78d7f1803cc7f793de4dea9cfdab
https://doi.org/10.4049/jimmunol.2001357
https://doi.org/10.4049/jimmunol.2001357
Autor:
Susan H Smith, Carlos E Peredo, Yukimasa Takeda, Thi Bui, Jessica Neil, David Rickard, Elizabeth Millerman, Jean-Philippe Therrien, Edwige Nicodeme, Jean-Marie Brusq, Veronique Birault, Fabrice Viviani, Hans Hofland, Anton M Jetten, Javier Cote-Sierra
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147979 (2016)
Psoriasis is a chronic inflammatory skin disorder involving marked immunological changes. IL-17-targeting biologics have been successful in reducing the disease burden of psoriasis patients with moderate-to-severe disease. Unfortunately, the stratum
Externí odkaz:
https://doaj.org/article/eafec2826fc340719a00dd38c007ee18
Autor:
Judy S. Paps, Javier Cote-Sierra, Carlos E. Peredo, David L. Mayhew, Deepak K. Rajpal, Thierry Olivry, Hans Hofland, Keith E. Linder
Publikováno v:
The Journal of investigative dermatology. 136(10)
Determining inflammation and itch pathway activation in patients with atopic dermatitis (AD) is fraught with the inability to precisely assess the age of skin lesions, thus affecting the analysis of time-dependent mediators. To characterize inflammat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75096d3f12cfab44df6e9122779cddc5
https://pubmed.ncbi.nlm.nih.gov/27342734
https://pubmed.ncbi.nlm.nih.gov/27342734
Autor:
David J. Rickard, Edwige Nicodeme, Jessica Neil, Javier Cote-Sierra, Véronique Birault, Anton M. Jetten, Susan H. Smith, Elizabeth Millerman, Thi Bui, Hans Hofland, Yukimasa Takeda, Fabrice Viviani, Jean-Marie Brusq, Jean-Philippe Therrien, Carlos E. Peredo
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 2, p e0147979 (2016)
PLoS ONE, Vol 11, Iss 2, p e0147979 (2016)
Background Psoriasis is a chronic inflammatory skin disorder involving marked immunological changes. IL-17-targeting biologics have been successful in reducing the disease burden of psoriasis patients with moderate-to-severe disease. Unfortunately, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ebff659de79b3a3b7f4a2c9d70b05aa
https://doi.org/10.1371/journal.pone.0147979
https://doi.org/10.1371/journal.pone.0147979